Interferon beta-1b FDA Link

A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.

Also Known As:

Betaseron; Beta-IFN-1b; Beta-Seron; Betaferon; Extavia; IFN-Beta Ser; Interferon Beta, Ser(17); Interferon Beta, Serine(17); Interferon beta 1b; Ser(17) IFN-beta; Serine(17) Interferon Beta; Beta Seron

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interferons: 39171
        Interferon Type I: 4788
        Interferon-beta: 3127
        Interferon beta-1b: 439
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interferons: 39171
        Interferon Type I: 4788
        Interferon-beta: 3127
        Interferon beta-1b: 439
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Cytokines: 164289
    - Interferons: 39171
      - Interferon Type I: 4788
        Interferon-beta: 3127
        Interferon beta-1b: 439

W Cendrowski Selected Research

W Cendrowski Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure